The first official presentation of TFOS DEWS II will occur at the 2017 ARVO Annual Meeting in Baltimore, Maryland.
Conclusions and recommendations from the TFOS Dry Eye Workshop II – SIG
Session Number: 125
Session Date/Start Time: May 7, 2017 from 1:30 PM to 3:00 PM
Room: Ballroom 4
The sequence of the TFOS DEWS II presentations are as follows:
Introduction – J Daniel Nelson
Definition & Classification – Jennifer Craig
Sex, Gender, & Hormones – David A. Sullivan
Epidemiology – Fiona Stapleton
Tear Film – Mark Willcox
Pain & Sensation – Carlos Belmonte
Pathophysiology – Anthony Bron
Iatrogenic Dry Eye – José Gomes
Diagnostic Methodology – James Wolffsohn
Management & Therapy – Lyndon Jones
Clinical Trial Design – Gary Novack
Please note: When published, the TFOS DEWS II Report will be freely available online, both on ScienceDirect (http://www.sciencedirect.com) and the Ocular Surface Journal’s (http://www.theocularsurfacejournal.com), homepage, indefinitely. Estimated time of publishing: end of June 2017.
We are still seeking companies to translate the TFOS DEWS II Report into additional languages. Please contact Amy for more information: Amy@TearFilm.org
More than 150 clinical and basic science experts from around the world have created this report. We express our sincere appreciation to all of you, as well as to the companies that have donated the funds to make this initiative possible: Title Sponsor: Alcon, Platinum Sponsor: Shire, Gold Sponsor: Allergan, Silver Sponsor: Bausch & Lomb, Bronze Sponsors: Akorn, CooperVision, Dompé, Horus, Lubris, Oculeve, TearLab, THEA, SIFI, Johnson & Johnson Vision Care and Sun Pharma Sponsors: Quint Health, Scope Ophthalmics, Senju and ZEISS.